{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:32:13Z","timestamp":1780921933091,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,2,5]],"date-time":"2007-02-05T00:00:00Z","timestamp":1170633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,2,5]],"date-time":"2007-02-05T00:00:00Z","timestamp":1170633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1038\/sj.bmt.1705579","type":"journal-article","created":{"date-parts":[[2007,2,5]],"date-time":"2007-02-05T09:27:44Z","timestamp":1170667664000},"page":"317-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"39","author":[{"given":"L","family":"Statkute","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Verda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Traynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Shook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Clifton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Satkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Yaung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Gonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Krosnjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Spahovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R K","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,2,5]]},"reference":[{"key":"BF1705579_CR1","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood.V85.9.2619.bloodjournal8592619","volume":"85","author":"S Fruehauf","year":"1995","unstructured":"Fruehauf S, Haas R, Conradt C, Murea S, Witt B, Mohle R et al. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy. Blood 1995; 85: 2619\u20132626.","journal-title":"Blood"},{"key":"BF1705579_CR2","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood.V86.6.2451.bloodjournal8662451","volume":"86","author":"AW Roberts","year":"1995","unstructured":"Roberts AW, Begley CG, Grigg AP, Basser RL . Do steady-state peripheral blood progenitor cell (PBPC) counts predict the yield of PBPC mobilized by filgrastim alone? Blood 1995; 86: 2451.","journal-title":"Blood"},{"key":"BF1705579_CR3","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1182\/blood.V87.8.3526b.bloodjournal8783526b","volume":"87","author":"B Husson","year":"1996","unstructured":"Husson B, Ravoet C, Dehon M, Wallef G, Hougardy N, Delannoy A . Predictive value of the steady-state peripheral blood progenitor cell (PBPC) counts for the yield of PBPC collected by leukapheresis after mobilization by granulocyte colony-stimulating factor (G-CSF) alone or chemotherapy and G-CSF. Blood 1996; 87: 3526\u20133528.","journal-title":"Blood"},{"key":"BF1705579_CR4","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1182\/blood.V87.12.5370.bloodjournal87125370","volume":"87","author":"DA Breems","year":"1996","unstructured":"Breems DA, van Hennik PB, Kusadasi N, Boudewijn A, Cornelissen JJ, Sonneveld P et al. Individual stem cell quality in leukapheresis products is related to the number of mobilized stem cells. Blood 1996; 87: 5370\u20135378.","journal-title":"Blood"},{"key":"BF1705579_CR5","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1200\/JCO.2000.18.9.1824","volume":"18","author":"ON Koc","year":"2000","unstructured":"Koc ON, Gerson SL, Cooper BW, Laughlin M, Meyerson H, Kutteh L et al. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF. J Clin Oncol 2000; 18: 1824\u20131830.","journal-title":"J Clin Oncol"},{"key":"BF1705579_CR6","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2000.18.16.3063","volume":"18","author":"L Akard","year":"2000","unstructured":"Akard L . Optimum methods to mobilize stem cells. J Clin Oncol 2000; 18: 3063.","journal-title":"J Clin Oncol"},{"key":"BF1705579_CR7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/sj.leu.2402867","volume":"17","author":"C Chabannon","year":"2003","unstructured":"Chabannon C, Le Corroller A-G, Viret F, Eillen C, Faucher C, Moatti J-P et al. Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation. Leukemia 2003; 17: 811\u2013820.","journal-title":"Leukemia"},{"key":"BF1705579_CR8","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1182\/blood.V83.12.3787.3787","volume":"83","author":"R Haas","year":"1994","unstructured":"Haas R, Mohle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787\u20133794.","journal-title":"Blood"},{"key":"BF1705579_CR9","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1182\/blood.V98.7.2059","volume":"98","author":"U Narayanasami","year":"2001","unstructured":"Narayanasami U, Kanteti R, Morelli J, Klekar A, Al-Olama A, Keating C et al. Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation. Blood 2001; 98: 2059\u20132064.","journal-title":"Blood"},{"key":"BF1705579_CR10","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1080\/1042819021000015899","volume":"43","author":"GL Deliliers","year":"2002","unstructured":"Deliliers GL, Annaloro C, Marconi M, Soligo D, Morandi P, Luchesini C et al. Harvesting of autologous blood stem cells after a mobilising regimen with low-dose cyclophosphamide. Leuk Lymph 2002; 43: 1957\u20131960.","journal-title":"Leuk Lymph"},{"key":"BF1705579_CR11","first-page":"272","volume":"30","author":"P Mollee","year":"2002","unstructured":"Mollee P, Pereira D, Nagy T, Song K, Saragosa R, Keating A et al. Cyclophosphamide, etoposide and G- CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma. Bone Marrow Tranpslant 2002; 30: 272\u2013278.","journal-title":"Bone Marrow Tranpslant"},{"key":"BF1705579_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/152581602753658475","volume":"11","author":"AL Petzer","year":"2002","unstructured":"Petzer AL, Hochenburger E, Haun M, Duba HC, Grunewald K, Hoflehner E et al. High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration. J Hematother Stem Cell Res 2002; 11: 293\u2013300.","journal-title":"J Hematother Stem Cell Res"},{"key":"BF1705579_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1046\/j.1365-2141.1998.00573.x","volume":"100","author":"CH Weaver","year":"1998","unstructured":"Weaver CH, Birch R, Greco FA, Schwartzberg L, McAneny B, Moore M et al. Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim. Br J Haematol 1998; 100: 338\u2013347.","journal-title":"Br J Haematol"},{"key":"BF1705579_CR14","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/sj.bmt.1702415","volume":"25","author":"S Yanovich","year":"2000","unstructured":"Yanovich S, Mitsky P, Cornetta K, Maziarz RT, Rosenfeld C, Krause DS et al. Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial. Bone Marrow Transplant 2000; 25: 1165\u20131174.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705579_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/152581602753658600","volume":"11","author":"KR Meehan","year":"2002","unstructured":"Meehan KR, Slack R, Gehan E, Herscowitz HB, Areman EM, Ebadi M et al. Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients. J Hematother Stem Cell Res 2002; 11: 415\u2013421.","journal-title":"J Hematother Stem Cell Res"},{"key":"BF1705579_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.leu.2402750","volume":"17","author":"F Prosper","year":"2003","unstructured":"Prosper F, Sola C, Hornedo J, Arbona C, Menendez P, Orfao A et al. Mobilization of peripheral blood progenitor cells with a combination of cyclophosphamide, r-metHuCSF and filgrastim in patients with breast cancer previously treated with chemotherapy. Leukemia 2003; 17: 437\u2013441.","journal-title":"Leukemia"},{"key":"BF1705579_CR17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1046\/j.1365-2141.1998.00730.x","volume":"101","author":"S Martin-Murea","year":"1998","unstructured":"Martin-Murea S, Voso MT, Hohaus S, Pforsich M, Fruehauf S, Golschmidt H et al. The dose of granulocyte colony-stimulating factor administered following cytotoxic chemotherapy is not related to the rebound level of circulating CD34+ haematopoietic progenitor cells during marrow recovery. Br J Haematol 1998; 101: 582\u2013585.","journal-title":"Br J Haematol"},{"key":"BF1705579_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1046\/j.1365-2141.2003.04107.x","volume":"120","author":"CL Morris","year":"2003","unstructured":"Morris CL, Siegel E, Barlogie B, Cottler-Fox M, Lin P, Fassas A et al. Mobilization of CD34+ cells in elderly patients (&gt;70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen. Br J Haematol 2003; 120: 413\u2013423.","journal-title":"Br J Haematol"},{"key":"BF1705579_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.bmt.1703662","volume":"30","author":"J Sevilla","year":"2002","unstructured":"Sevilla J, Gonzalez-Vicent M, Madero L, Garcia-Sanchez F, Diaz MA . Granulocyte colony-stimulating factor alone at 12\u2009\u03bcg\/kg twice a day for 4 days for peripheral blood progenitor cell priming in pediatric patients. Bone Marrow Transplant 2002; 30: 417\u2013420.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705579_CR20","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V91.9.3148","volume":"91","author":"N Ketterer","year":"1998","unstructured":"Ketterer N, Salles G, Raba M, Espinouse D, Sonet A, Tremisi P et al. High CD34+ cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation. Blood 1998; 91: 3148\u20133155.","journal-title":"Blood"},{"key":"BF1705579_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/sj.bmt.1703619","volume":"30","author":"PR Gordon","year":"2002","unstructured":"Gordon PR, Leimig T, Mueller I, Babarin-Dorner A, Holladay MA, Houston J et al. A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cells. Bone Marrow Transplant 2002; 30: 69\u201374.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705579_CR22","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood.V85.11.3048.bloodjournal85113048","volume":"85","author":"CE Dunbar","year":"1995","unstructured":"Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995; 85: 3048\u20133057.","journal-title":"Blood"},{"key":"BF1705579_CR23","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1046\/j.1365-2141.2000.02438.x","volume":"111","author":"F De Boer","year":"2000","unstructured":"De Boer F, Drager AM, Van Haperen MJAM, Van der Wall E, Kessler F, Huijgens PC et al. The phenotypic profile of CD34-positive peripheral blood stem cells in different mobilization regimens. Br J Haematol 2000; 111: 1138\u20131144.","journal-title":"Br J Haematol"},{"key":"BF1705579_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1089\/scd.1.1996.5.213","volume":"5","author":"DR Sutherland","year":"1996","unstructured":"Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I . The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996; 5: 213\u2013226.","journal-title":"J Hematother"},{"key":"BF1705579_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/bbmt.1998.v4.pm9763111","volume":"4","author":"EJ Shpall","year":"1998","unstructured":"Shpall EJ, Champlin R, Glaspy JA . Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery. Biol Blood Marrow Transplant 1998; 4: 84\u201392.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705579_CR26","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1089\/15258160260194875","volume":"11","author":"J Gryn","year":"2002","unstructured":"Gryn J, Shadduck RK, Lister J, Zeigler ZR, Raymond JM . Factors affecting purification of CD34+ peripheral blood stem cells using Baxter Isolex 300i. J Hematother Stem Cell Res 2002; 11: 719\u2013730.","journal-title":"J Hematother Stem Cell Res"},{"key":"BF1705579_CR27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1046\/j.1365-2141.2003.04483.x","volume":"122","author":"S Fruehauf","year":"2003","unstructured":"Fruehauf S, Seggewiss R . It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement (review). Br J Haematol 2003; 122: 360\u2013375.","journal-title":"Br J Haematol"},{"key":"BF1705579_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00281-004-0162-6","volume":"26","author":"RK Burt","year":"2004","unstructured":"Burt RK, Verda L, Oyama Y, Statkute L, Slavin S . Non-myeloablative stem cell transplantation for autoimmune diseases. Springer Semin Immunopathol 2004; 26: 57\u201369.","journal-title":"Springer Semin Immunopathol"},{"key":"BF1705579_CR29","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nature03728","volume":"435","author":"M Sykes","year":"2005","unstructured":"Sykes M, Nikolic B . Treatment of severe autoimmune disease by stem-cell transplantation. Nature 2005; 435: 620\u2013627.","journal-title":"Nature"},{"key":"BF1705579_CR30","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1365-2141.2004.05076.x","volume":"126","author":"U Popat","year":"2004","unstructured":"Popat U, Krance R . Haematopoietic stem cell transplantation for autoimmune disorders: the American perspective. Br J Haematol 2004; 126: 637\u2013649.","journal-title":"Br J Haematol"},{"key":"BF1705579_CR31","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1365-2141.2004.05298.x","volume":"128","author":"RE Hough","year":"2005","unstructured":"Hough RE, Snowden JA, Wulffraat NM . Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective. Br J Haematol 2005; 128: 432\u2013459.","journal-title":"Br J Haematol"},{"key":"BF1705579_CR32","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1002\/art.22256","volume":"54","author":"RK Burt","year":"2006","unstructured":"Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthr Rheum 2006; 54: 3750\u20133760.","journal-title":"Arthr Rheum"},{"key":"BF1705579_CR33","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1002\/art.1780401017","volume":"40","author":"D McGonagle","year":"1997","unstructured":"McGonagle D, Rawstron A, Richards S, Isaacs J, Bird H, Jack A et al. A phase 1 study to address the safety and efficacy of granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis. Arthr Rheum 1997; 40: 1838\u20131842.","journal-title":"Arthr Rheum"},{"key":"BF1705579_CR34","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/sj.bmt.1701486","volume":"22","author":"JA Snowden","year":"1998","unstructured":"Snowden JA, Biggs JC, Miliken ST, Fuller A, Staniforth D, Passuello F et al. A randomized, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for hematopoietic stem cell mobilization in patients with severe active rheumatoid arthritis. Bone Marrow Transplant 1998; 22: 1035\u20131041.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705579_CR35","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1002\/1529-0131(199911)42:11<2275::AID-ANR3>3.0.CO;2-6","volume":"42","author":"M Breban","year":"1999","unstructured":"Breban M, Dougados M, Picard F, Zompi S, Marolleau J-P, Bocaccio C et al. Intensified-dose (4\u2009g\/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritis. Arthr Rheum 1999; 42: 2275\u20132280.","journal-title":"Arthr Rheum"},{"key":"BF1705579_CR36","first-page":"839","volume":"84","author":"F Locatelli","year":"1999","unstructured":"Locatelli F, Perotti C, Torretta L, Maccario R, Montagna D, Ravelli A et al. Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosis. Haematologica 1999; 84: 839\u2013843.","journal-title":"Haematologica"},{"key":"BF1705579_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bmt.1703081","volume":"28","author":"RK Burt","year":"2001","unstructured":"Burt RK, Fassas A, Snowden JA, van Laar JM, Kozak T, Wulffraat NM et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 2001; 28: 1\u201312.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705579_CR38","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1212\/WNL.54.11.2147","volume":"54","author":"H Openshaw","year":"2000","unstructured":"Openshaw H, Stuve O, Antel JP, Nash R, Lund BT, Weiner LP et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology 2000; 54: 2147\u20132150.","journal-title":"Neurology"},{"key":"BF1705579_CR39","first-page":"2153","volume":"24","author":"HH Euler","year":"1997","unstructured":"Euler HH, Harten P, Zeuner RA, Schwab UM . Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections. J Rheumatol 1997; 24: 2153\u20132157.","journal-title":"J Rheumatol"},{"key":"BF1705579_CR40","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1002\/1529-0131(200110)44:10<2458::AID-ART420>3.0.CO;2-B","volume":"44","author":"JE Gottenberg","year":"2001","unstructured":"Gottenberg JE, Roux S, Desmoulins F, Clerc D, Mariette X . Granulocyte colony-stimulating factor therapy resulting in a flare of systemic lupus erythematosus: comment on the article by Yang and Hamilton. Arthr Rheum 2001; 44: 2458\u20132460.","journal-title":"Arthr Rheum"},{"key":"BF1705579_CR41","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/sj.bmt.1701422","volume":"22","author":"S Hohaus","year":"1998","unstructured":"Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Farber L et al. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells. Bone Marrow Transplant 1998; 22: 625\u2013630.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705579_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1046\/j.1365-2141.1998.00960.x","volume":"103","author":"N Ketterer","year":"1998","unstructured":"Ketterer N, Salles G, Moullet I, Dumontet C, ElJaafari-Corbin A, Tremisi P et al. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol 1998; 103: 235\u2013242.","journal-title":"Br J Haematol"},{"key":"BF1705579_CR43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/(SICI)1096-8652(199808)58:4<255::AID-AJH1>3.0.CO;2-P","volume":"58","author":"G D'Arena","year":"1998","unstructured":"D'Arena G, Musto P, Di Mauro L, Cascavilla N, Iacono ND, Scalzulli PR et al. Predictive parameters for mobilized peripheral blood CD34+ progenitor cell collection in patients with hematological malignancies. Am J Hematol 1998; 58: 255\u2013262.","journal-title":"Am J Hematol"},{"key":"BF1705579_CR44","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1200\/JCO.1997.15.2.684","volume":"15","author":"T Demirer","year":"1997","unstructured":"Demirer T, Buckner CD, Storer B, Lilleby K, Rowley S, Clift R et al. Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor. J Clin Oncol 1997; 15: 684\u2013690.","journal-title":"J Clin Oncol"},{"key":"BF1705579_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/stem.170055","volume":"17","author":"C Tarella","year":"1999","unstructured":"Tarella C, Zallio F, Caracciolo D, Cherasco C, Bondesan P, Gavarotti P et al. Hematopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patients. Stem Cells 1999; 17: 55\u201361.","journal-title":"Stem Cells"},{"key":"BF1705579_CR46","first-page":"342","volume":"84","author":"B Sautois","year":"1999","unstructured":"Sautois B, Fraipont V, Baudoux E, Fassotte MF, Hermanne JP, Jerusalem G et al. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields. Haematologica 1999; 84: 342\u2013349.","journal-title":"Haematologica"},{"key":"BF1705579_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1620\/tjem.199.111","volume":"199","author":"Y Kudo","year":"2003","unstructured":"Kudo Y, Minegishi M, Saito N, Itoh T, Fushimi J, Takahashi H et al. The absolute number of peripheral blood CD34+ cells predicts a timing for apheresis and progenitor cell yield in patients with hematologic malignancies and solid tumors. Tohoku J Exp Med 2003; 199: 111\u2013118.","journal-title":"Tohoku J Exp Med"},{"key":"BF1705579_CR48","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/sj.bmt.1703520","volume":"29","author":"J Mehta","year":"2002","unstructured":"Mehta J, Singhal S, Gordon L, Tallman M, Williams S, Luyun R et al. Cobe Spectra is superior to Fenwal CS 3000 Plus for collection of hematopoietic stem cells. Bone Marrow Transplantation 2002; 29: 563\u2013567.","journal-title":"Bone Marrow Transplantation"},{"key":"BF1705579_CR49","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1046\/j.1537-2995.2001.41121562.x","volume":"41","author":"WE Hitzler","year":"2001","unstructured":"Hitzler WE, Wolf S, Runkel S, Kunz-Kostomanolakis M . Comparison of intermittent- and continuous-flow cell separators for the collection of autologous peripheral blood progenitor cells in patients with hematologic malignancies. Transfusion 2001; 41: 1562\u20131566.","journal-title":"Transfusion"},{"key":"BF1705579_CR50","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1089\/152581600419242","volume":"9","author":"D Despres","year":"2000","unstructured":"Despres D, Flohr T, Uppenkamp M, Baldus M, Hoffmann M, Huber C et al. CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACS device. J Hematother Stem Cell Res 2000; 9: 557\u2013564.","journal-title":"J Hematother Stem Cell Res"},{"key":"BF1705579_CR51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1089\/106161299320488","volume":"8","author":"M Schumm","year":"1999","unstructured":"Schumm M, Lang P, Taylor G, Kuci S, Klingebiel T, Buhring HJ et al. Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother 1999; 8: 209\u2013218.","journal-title":"J Hematother"},{"key":"BF1705579_CR52","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood.V86.10.3961.bloodjournal86103961","volume":"86","author":"C Weaver","year":"1995","unstructured":"Weaver C, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961\u20133969.","journal-title":"Blood"},{"key":"BF1705579_CR53","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1399-0012.2006.00512.x","volume":"20","author":"I Kim","year":"2006","unstructured":"Kim I, Yoon SS, Lee K-H, Keam B, Kim TM, Kim J-S et al. Comparative outcomes of reduced intensity and myeloablative allogeneic hematopoietic stem cell transplantation in patients under 50 with hematologic malignancies. Clin Transplant 2006; 20: 496\u2013503.","journal-title":"Clin Transplant"},{"key":"BF1705579_CR54","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/scd.2004.13.571","volume":"13","author":"J Vela-Ojeda","year":"2004","unstructured":"Vela-Ojeda J, Garcia-Ruiz Esparza MA, Tripp-Villanueva F, Ayala-Sanchez M, Delgado-Lamas JL, Garces-Ruiz O et al. Allogeneic peripheral blood stem cell transplantation using reduced intensity versus myeloablative conditioning regimens for the treatment of leukemia. Stem Cells Dev 2004; 13: 571\u2013578.","journal-title":"Stem Cells Dev"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705579.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705579","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705579.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:18:34Z","timestamp":1648081114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,5]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["BF1705579"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705579","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,5]]},"assertion":[{"value":"6 December 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}